Public Profile

Alcami

Alcami Corporation, commonly referred to as Alcami, is a leading contract development and manufacturing organisation (CDMO) headquartered in the United States. Established in 2015, Alcami has rapidly expanded its operational footprint across key regions, including North America and Europe, to serve a diverse clientele in the pharmaceutical and biotechnology sectors. Specialising in integrated solutions for drug development, Alcami offers a comprehensive range of services, including analytical testing, formulation development, and sterile manufacturing. What sets Alcami apart is its commitment to quality and innovation, ensuring that clients receive tailored solutions that meet stringent regulatory standards. With a strong market position, Alcami has achieved notable milestones, reinforcing its reputation as a trusted partner in the life sciences industry.

DitchCarbon Score

How does Alcami's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Alcami's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Alcami's reported carbon emissions

Alcami, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of emissions data suggests that Alcami may be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for companies like Alcami to establish clear climate commitments and reduction targets to align with global efforts in mitigating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alcami's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alcami is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alcami is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aenova Group GmbH

DE
Real estate services (70)
Updated 3 months ago
DitchCarbon Score

Catalent

US
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Johnson Matthey

GB
Chemicals nec
Updated 3 days ago

Societal CDMO, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Patheon BV

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Quotient Sciences Limited

GB
Research and development services (73)
Updated about 2 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers